Cargando…
Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: The presence of an untreated chronic total coronary occlusion (CTO) is associated with a higher risk of ventricular arrhythmias (VAs). This increased risk may be modulated by the presence of existing scar. We hypothesize that a lar...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207331/ http://dx.doi.org/10.1093/europace/euad122.259 |
_version_ | 1785046429390077952 |
---|---|
author | Hindi-Assaf, A Van Der Graaf, M Van Boven, N Van Ettinger, M J B Hoogendijk, M Diletti, R Szili-Torok, T Theuns, D A M J Yap, S C |
author_facet | Hindi-Assaf, A Van Der Graaf, M Van Boven, N Van Ettinger, M J B Hoogendijk, M Diletti, R Szili-Torok, T Theuns, D A M J Yap, S C |
author_sort | Hindi-Assaf, A |
collection | PubMed |
description | FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: The presence of an untreated chronic total coronary occlusion (CTO) is associated with a higher risk of ventricular arrhythmias (VAs). This increased risk may be modulated by the presence of existing scar. We hypothesize that a larger scar size is associated with a higher risk of VA. OBJECTIVES: To evaluate whether infarct size is associated with VA in patients with an implantable cardioverter-defibrillator (ICD) and an untreated CTO. METHODS: In this retrospective study we included patients with an untreated CTO that received an ICD between 2005 and 2014. Infarct size was estimated using the Selvester QRS score on a baseline 12-lead ECG. The primary endpoint was any appropriate ICD therapy. RESULTS: Our study population comprised 148 patients (mean age at implantation 64 ± 10 years, 87% men) with an ICD and an untreated CTO. The median infarct size at baseline was 18% (IQR, 9-27%). Patients with a larger scar size (≥18%) more often had a CTO location in the LAD, higher proportion of LVEF <35%, and less hypertension and hypercholesterolemia compared to patients with a smaller infarct size (<18%). During a median follow-up of 35 months (interquartile range [IQR], 8-60 months), 42 patients (28%) received appropriate ICD therapy. The cumulative 5-year event rate was higher in the patients with a large infarct size (≥18%) in comparison to those with a smaller infarct size (<18%) (36% versus 19%, logrank P = 0.038, Figure). Multivariable Cox regression analysis demonstrated that a larger infarct size (≥18%) and a secondary prevention indication were independent factors associated with appropriate ICD therapy. The adjusted hazard ratio of large infarct size (≥18%) for appropriate ICD therapy was 2.34 (95% CI 1.20-4.58, p=0.01). CONCLUSION: In ICD recipients with an untreated CTO, a larger scar size is an independent factor associated with an increased risk of VA. [Figure: see text] |
format | Online Article Text |
id | pubmed-10207331 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-102073312023-05-25 Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion Hindi-Assaf, A Van Der Graaf, M Van Boven, N Van Ettinger, M J B Hoogendijk, M Diletti, R Szili-Torok, T Theuns, D A M J Yap, S C Europace 13.1 - Pathophysiology and Mechanisms FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: The presence of an untreated chronic total coronary occlusion (CTO) is associated with a higher risk of ventricular arrhythmias (VAs). This increased risk may be modulated by the presence of existing scar. We hypothesize that a larger scar size is associated with a higher risk of VA. OBJECTIVES: To evaluate whether infarct size is associated with VA in patients with an implantable cardioverter-defibrillator (ICD) and an untreated CTO. METHODS: In this retrospective study we included patients with an untreated CTO that received an ICD between 2005 and 2014. Infarct size was estimated using the Selvester QRS score on a baseline 12-lead ECG. The primary endpoint was any appropriate ICD therapy. RESULTS: Our study population comprised 148 patients (mean age at implantation 64 ± 10 years, 87% men) with an ICD and an untreated CTO. The median infarct size at baseline was 18% (IQR, 9-27%). Patients with a larger scar size (≥18%) more often had a CTO location in the LAD, higher proportion of LVEF <35%, and less hypertension and hypercholesterolemia compared to patients with a smaller infarct size (<18%). During a median follow-up of 35 months (interquartile range [IQR], 8-60 months), 42 patients (28%) received appropriate ICD therapy. The cumulative 5-year event rate was higher in the patients with a large infarct size (≥18%) in comparison to those with a smaller infarct size (<18%) (36% versus 19%, logrank P = 0.038, Figure). Multivariable Cox regression analysis demonstrated that a larger infarct size (≥18%) and a secondary prevention indication were independent factors associated with appropriate ICD therapy. The adjusted hazard ratio of large infarct size (≥18%) for appropriate ICD therapy was 2.34 (95% CI 1.20-4.58, p=0.01). CONCLUSION: In ICD recipients with an untreated CTO, a larger scar size is an independent factor associated with an increased risk of VA. [Figure: see text] Oxford University Press 2023-05-24 /pmc/articles/PMC10207331/ http://dx.doi.org/10.1093/europace/euad122.259 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | 13.1 - Pathophysiology and Mechanisms Hindi-Assaf, A Van Der Graaf, M Van Boven, N Van Ettinger, M J B Hoogendijk, M Diletti, R Szili-Torok, T Theuns, D A M J Yap, S C Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion |
title | Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion |
title_full | Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion |
title_fullStr | Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion |
title_full_unstemmed | Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion |
title_short | Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion |
title_sort | effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion |
topic | 13.1 - Pathophysiology and Mechanisms |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207331/ http://dx.doi.org/10.1093/europace/euad122.259 |
work_keys_str_mv | AT hindiassafa effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion AT vandergraafm effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion AT vanbovenn effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion AT vanettingermjb effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion AT hoogendijkm effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion AT dilettir effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion AT szilitorokt effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion AT theunsdamj effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion AT yapsc effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion |